Close

United Therapeutics (UTHR) Tops Q4 EPS Views

February 25, 2016 6:18 AM EST

United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.68, $1.13 better than the analyst estimate of $2.55. Revenue for the quarter came in at $404.9 million versus the consensus estimate of $388.29 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings